Wockhardt – Express Pharma

Wockhardt Q2 net profit zooms over 11-fold to Rs 37.17 crores

Redefining job roles to build competitive compliance

Wockhardt and Jemincare partner for novel respiratory antibiotic Nafithromycin

RDIF and Wockhardt partner to produce Sputnik V and Sputnik Light vaccines

High Commissioner of India visits Wockhardt UK

UK government extends contract with Wockhardt to fill-finish COVID-19 vaccines

Wockhardt signs partnership with UK Government to fill-finish COVID-19 vaccine

Dr Reddy’s Laboratories completes acquisition of Wockhardt’s select business divisions

Wockhardt Q4 results: Firm posts profit of Rs 69 crore after loss in Q4FY19

Wockhardt’s QIDP status for WCK 6777 reflects unmet need and untapped market opportunity: GlobalData